About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Immunotherapy More Effective and Long Lasting If T Cell ‘memory’ is Boosted

by Anjali Aryamvally on April 17, 2018 at 2:41 PM
Font : A-A+

Immunotherapy More Effective and Long Lasting If T Cell ‘memory’ is Boosted

Subtypes of T cells known as memory T cells may explain why some immunotherapies are more effective than others, according to a new study from the University of Texas MD Anderson Cancer Center. The study findings could potentially lead to researchers designing more effective studies using combination checkpoint blockade treatments.

The study demonstrated that anti-CTLA-4 and anti- PD-1 immunotherapies together appear to enhance response rates and generate formation of memory T cells in mice vaccinated with melanoma cells. The combination could explain why relapse occurs in some patients with therapies targeting CTLA-4 and PD-1 checkpoints, which evade the body's immune system.

Advertisement


Findings from the study conducted in the lab of checkpoint blockade pioneer, James Allison, Ph.D., chair of Immunology, were presented today at the American Association for Cancer Research Annual Meeting 2018 in Chicago.

"We are learning more about the differences between anti-CTLA-4 and anti-PD-1 therapies," said Stephen Mok, Ph.D., postdoctoral fellow of Immunology, who presented findings. "We know that while anti-PD-1 therapy has a greater response rate than anti-CTLA-4, one issue is the durability of the responses."
Advertisement

Patients who receive anti-PD-1 have an average response rate of 30 percent but approximately 25 percent of the patients experience tumor relapse within two years after treatment has stopped. Patients treated with anti-CTLA-4 have a response rate of 11 percent with 22 percent of patients surviving at least 10 years.

The team took a closer look at memory T cells, which in previous bacteria and virus studies have suggested anti-CTLA-4 increases memory T cell levels. Conversely, anti-PD-1 tends to reduce their formation. Memory T cells are immune cells that previously have encountered cancer and gained the ability to recognize cancer antigens and reproduce more quickly, resulting in a faster and stronger defense. The investigators vaccinated mice with irradiated melanoma cells and treated them with either anti-CTLA-4 or anti-PD-1 to see if there were differences in memory T cell formation.

"Although both anti-CTLA-4 and anti-PD-1 improved tumor rejection, mice treated with anti-CTLA-4 exhibited superior tumor control, suggesting the memory T-cell response by this agent is more durable," said Allison. "In order to augment the durability of anti-PD-1 treatment, it was combined with anti-CTLA-4. What we found was that the combined treatment group had a better memory anti-tumor response compared with anti-PD-1 alone."

The team reported that collectively their findings facilitate the design of combination immunotherapy treatments that enhance both response rates and generation of memory T cells to prevent relapse.

"Understanding how checkpoint blockade therapies affect memory T-cell development opens up the possibilities for refining current combination immunotherapy treatments and improving patient outcomes," said Mok.

Colm Duffy, a graduate research assistant in the Graduate School of Biomedical Sciences, Immunology, also participated in the study. Mok is funded by the Cancer Research Institute Irvington Postdoctoral Fellowship (16073450).



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Turmeric: Magic Ingredient to Keep you Healthy in Winter
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Parkinsons Disease Surgical Treatment Immunisation Dealing with Pollen Allergy Immune Checkpoint Inhibitors for Cancer Treatment 

Recommended Reading
Here's How Heart Cells Develop
Cardiomyocytes arise from stem cell-like precursor cells that have proliferative potential and are ....
Brown Fat Cells Burn Energy, Help in Weight Loss
Brown fat cells that were found to regulate babies body temperature also play an important role by ....
Understanding the Structure of a Nanoscaffold for Heart Cells
High-resolution 3D microscopy study of cardiomyocytes on polymer scaffold nanofibers reveals the ......
Pericytes in Brain can Compensate for Lost Cells
Using advanced imaging of living cells, pericytes grow to compensate for the loss of neighboring ......
Dealing with Pollen Allergy
The plants around you that give you sniffles in your nose at specific time of the year are the sourc...
Immune Checkpoint Inhibitors for Cancer Treatment
Immune checkpoint inhibitors are promising drugs to treat a variety of cancers and the FDA has appro...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use